We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Pulmonary Eosinophilia Indicates Onset of Allergic Bronchopulmonary Aspergillosis

By LabMedica International staff writers
Posted on 13 Dec 2021
Print article
Image: Histopathology of Allergic bronchopulmonary aspergillosis. Grocott\'s Methenamine Silver Stain  shows branching and helps to confirm that the black structures are indeed fungal hyphae (Photo courtesy of Doctorlib)
Image: Histopathology of Allergic bronchopulmonary aspergillosis. Grocott\'s Methenamine Silver Stain shows branching and helps to confirm that the black structures are indeed fungal hyphae (Photo courtesy of Doctorlib)
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder caused by type 2 immune responses to Aspergillus. This pathology usually develops after the onset of bronchial asthma (BA) or cystic fibrosis. Rates differ among countries, but appear to be increasing around the world with the increase of BA.

Several diagnostic criteria for ABPA have been proposed, such as a history of BA or cystic fibrosis, characteristic radiographic pulmonary opacities including central dilatation of the bronchus, elevated immunoglobulin (Ig)E levels, and hypersensitivity reaction to Aspergillus including elevated IgE antibodies against Aspergillus fumigatus and/or IgG antibodies for Aspergillus. ABPA and chronic eosinophilic pneumonia (CEP) both display peripheral eosinophilia as well as pulmonary infiltration, together described as pulmonary eosinophilia, and differentiation is sometimes problematic.

Pulmonologists at the Osaka Toneyama Medical Center (Osaka, Japan) performed a retrospective, single-center study that included patients that fulfilled the diagnostic criteria for ABPA, which included a history of BA or cystic fibrosis and both of the following: positive immediate cutaneous hypersensitivity to Aspergillus antigen or specific IgE to A. fumigatus, and elevated total IgE level in serum  > 1000 IU/mL. Also the presence of precipitating or IgG antibodies against A. fumigatus in serum; pulmonary opacities consistent with ABPA on radiographic imaging; and total eosinophil count  > 500 cells/µL in steroid-naïve patients were considered.

Patients were assigned to either the eosinophilic pneumonia (EP) group or Non-EP group, defined according to findings on high-resolution computed tomography (HRCT). The EP group included patients with HRCT findings compatible with CEP; i.e., the presence of peripheral consolidation (p-consolidation) or ground-glass opacities (GGO), with no evidence of high-attenuation mucus. The Non-EP group comprised the remaining patients, who showed classical findings of ABPA such as mucoid impaction. Differences between the groups were analyzed.

The investigators reported that baseline characteristics, frequency of a history of CEP (EP, 50% versus Non-EP, 26%) and tentative diagnosis of CEP before diagnosis of ABPA (67% versus 16%) did not differ significantly between groups. Although elevated absolute eosinophil count and Aspergillus-specific immunoglobulin E titers did not differ significantly between groups, the Non-EP group showed a strong positive correlation between these values (R  = 0.7878). All patients showed peripheral eosinophilia (median, 1,540 cells/μL), elevated level of IgE (median, 2,802 IU/mL) and positive reactions for Aspergillus-specific IgE (median, 20.7 IU/mL).

The Non-EP group displayed significantly higher levels of the fungal marker beta-D glucan (median, 11.7 pg/mL; interquartile range, 6.7–18.4 pg/mL) than the EP group (median, 6.6 pg/mL; interquartile range, 5.2–9.3 pg/ml). Both groups exhibited frequent recurrence of shadows on X-rays but no cases in the EP group had progressed to the Non-EP group at the time of relapse.

The authors concluded that the ABPA subgroup with imaging findings resembling CEP experienced frequent recurrences, as in typical ABPA. In pulmonary eosinophilia, even if there are no shadows indicating apparent mucous change, the Aspergillus-specific immunoglobulin E level is important in obtaining an accurate diagnosis and in the selection of appropriate therapies for this type of ABPA. The study was published on November 18, 2021 in the journal Allergy, Asthma & Clinical Immunology.

Related Links:
Osaka Toneyama Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.